dose conversion tirzepatide to semaglutide vs dosage chart: complete comparison guide Switching between weight-loss medications -
Description
(2022) Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
Armstrong LE et al
Indeed, a study published in Diabetes, Obesity and Metabolism found that people regained two-thirds of their original weight a year after stopping the drug semaglutide
Semaglutide's anti-inflammatory properties add another layer of support
